Atelocollagen IOC medicine

Atelocollagen: A revolution in transplant medicine and oral surgery

summary

Atelocollagen, a form of collagen without telopeptides, thanks to its reduced immunogenicity, has found wide application in regenerative medicine, transplantology and oral surgery. It is valued for its ability to accelerate healing processes and tissue regeneration, which makes it a key material in modern medical procedures.

1. Introduction

Collagen, the main structural protein in connective tissue, is a key component supporting tissue regeneration and healing. Atelocollagen, obtained by enzymatic removal of telopeptides from native collagen, is characterized by a minimized ability to induce an immune response. Its biocompatibility and biodegradability make it ideal for medical applications where traditional biomaterials could provoke transplant rejection or allergic reactions.

2. Atelocollagen in oral surgery

In oral surgery, atelocollagen is mainly used to promote healing after tooth extractions, where its use has shown significant benefits in the regeneration of bone and gingival tissue. A study conducted by Iwata and colleagues (2010) showed that atelocollagen sponges used in tooth extraction sites contributed to increased expression of type I collagen mRNA, which is important for bone regeneration. Moreover, the use of atelocollagen significantly reduces the risk of complications by stimulating natural healing processes.

3. Atelocollagen in transplant medicine

Atelocollagen is used in transplantology as a scaffold for cells, supporting their adhesion, proliferation and differentiation. Its use is crucial in the context of tissue culture, where it serves as a matrix for cultured cells. For example, research on the use of atelocollagen to heal wounds in diabetic mice has shown that its use in combination with autologous stem cells significantly accelerates tissue regeneration.

4. Innovative applications of atelocollagen

The development of biomaterial technology opens up new possibilities for the use of atelocollagen. Its application is currently expanding to tissue engineering, where it supports the reconstruction of large tissue defects. Atelocollagen is also being studied in the context of creating bioartificial organs, such as blood vessels or skin, where its properties are used to create structures resembling natural tissues. Atelocollagen is also being considered as an effective carrier of therapeutics, as described in detail in the work of Wysocki et al. in 2007, where its potential use in gene therapy and drug delivery was studied. Atelocollagen, thanks to its unique properties such as low immunogenicity, stability at different temperatures and the ability to form stable complexes with proteins and nucleic acids, can effectively protect therapeutic molecules in the body and release them in a controlled manner. The authors indicate that atelocollagen can serve as a safe and effective carrier for antisense therapy, RNAi and other therapeutic strategies that require precise delivery of molecular factors to target cells. These applications include the treatment of hereditary diseases, cancers, and other pathological conditions, making atelocollagen a promising material in modern regenerative and molecular medicine. The results of the research by Wysocki and colleagues may significantly contribute to the development of more effective and safer treatments, especially in gene therapy and drug delivery.

5. The future of atelocollagen in medicine

Future research on atelocollagen will focus on further understanding its interactions with human cells in the context of its immunological and regenerative properties. Progress in nanomedical technologies and tissue bioengineering may enable even broader use of atelocollagen in medicine, from soft tissue reconstruction to advanced drug delivery systems.

End

Atelocollagen, thanks to its unique properties, is becoming the foundation of modern medical and surgical techniques. Its role in regenerative medicine and transplantology will continue to grow as new applications and technologies are developed. IOC has its own technology for producing this protein.
REFERENCES
  1. Iwata, S., Matsuzaka, K., Inoue, T. (2010). Effects of an atelocollagen sponge during the wound healing of tooth extraction sockets at an early stage. Oral Medicine & Pathology, 15(1), 15-20. Available online: https://www.jstage.jst.go.jp/article/omp/15/1/15_1_15/_article/-char/ja/
  2. Kajiwara, K., Tanemoto, T., Wada, S., Karibe, J., Ihara, N., Ikemoto, Y., Kawasaki, T., Oishi, Y., Samura, O., Okamura, K., Takada, S., Akutsu, H., Sago, H., Okamoto, A., Umezawa, A. (2017). Fetal Therapy Model of Myelomeningocele with Three-Dimensional Skin Using Amniotic Fluid Cell-Derived Induced Pluripotent Stem Cells. Stem Cell Reports, 8 (6), 1701-1713. DOI: https://doi.org/10.1016/j.stemcr.2017.05.009
  3. Minabe, M., Kodama, T., Hori, T., Watanabe, Y. (1989). Effects of atelocollagen on the wound healing reaction following palatal gingivectomy in rats. Journal of Periodontal Research, 24 (3), 188-195. DOI: https://doi.org/10.1111/j.1600-0765.1989.tb02003.x
  4. Nambu, M., Kishimoto, S., Nakamura, S., Mizuno, H., Yanagibayashi, S., Yamamoto, N., Azuma, R., Nakamura, S.I., Kiyosawa, T., Ishihara, M., Kanatani , Y (2009). Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Annals of Plastic Surgery, 62 (3), 317-321. DOI: https://doi.org/10.1097/SAP.0b013e31817f01b6
  5. Yu, S.-J., Moon, S.-S., Jang, H.-S., Han, K.-Y., Hwang, K.-S., Choi, S.-H., Kwon, Y.-H., Kim, B.-O. (2012). A clinical and histological evaluation for healing of dehiscence defects filled with an absorbable atelocollagen sponge in dogs. Tissue Engineering and Regenerative Medicine, 9, 320–327. DOI: https://doi.org/10.1007/s13770-012-0329-5
  6. Wysocki, T., Sacewicz, I., Wiktorska, M., Niewiarowska, J. (2007). Atelocollagen as a potential carrier of therapeutics. Progress Hig Med Exp (online), 61: 646-654. e-ISSN 1732-2693. Available online: https://phmd.pl/resources/html/article/details?id=6899&language=en
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookie settings
Accept
Privacy & Cookie policy
Privacy & Cookies policy
cookie name Active

Who we are

suggested text: We are IOC sp. z o. o. Our website address is: https://producentsuplementow.pl.

Comments

When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://producentsuplementow.pl/polityka-prywatnosci/🇧🇷 After approval of your comment, your profile picture is visible to the public in the context of your comment.

Media

suggested text: If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.

Cookies

If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year. If you visit our login page, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser. When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select "Remember Me", your login will persist for two weeks. If you log out of your account, the login cookies will be removed. If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.

Embedded content from other websites

Articles on this site may include embedded content (e.g., videos, images, articles, etc.). Embedded content from other websites behaves in exactly the same way as if the visitor has visited the other website. These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with the embedded content, including tracking your interaction with the embedded content.

Who we share your data with

If you request a password reset, your IP address will be included in the reset email.

How long we keep your data

If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue. For users who register on our website (if any), we also store the personal information they provide in their user profile. All users can view, edit or delete their personal information at any time (except they can not change their username). Website administrators can also view and edit that information.

What rights do you have over your data

If you have an account on this site, or have left comments, you may request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You may also request that we erase any personal data we hold about you. This does not include any data we are required to keep for administrative, legal, or security purposes.

Where is your data sent

Visitor comments may be checked through an automated spam detection service.
Save settings
Cookie settings
Scroll to Top